Peripheral inflammation can trigger a number of neuroinflammatory events in the CNS, such as activation of microglia and increases of proinflammatory cytokines. We have previously identified an interesting phenomenon, termed ''euflammation", which can be induced by repeated subthreshold infectious challenges. Euflammation causes innate immune alterations without overt neuroimmune activation. In the current study, we examined the protective effect of euflammation against peripheral inflammationinduced neuroinflammation and the underlying mechanisms. When Escherichia coli or lipopolysaccharide (LPS) was injected inside or outside the euflammation induction locus (EIL), sickness behavior, global microglial activation, proinflammatory cytokine production in the brain, expression of endothelial cyclooxygenase II and induction of c-fos expression in the paraventricular nucleus of the hypothalamus were all attenuated in the euflammatory mice compared with those in the control unprimed mice. Euflammation also modulated innate immunity outside the EIL by upregulating receptors for pathogen-associated molecular patterns in spleen cells. In addition, euflammation attenuated CNS activation in response to an intra-airpouch (outside the EIL) injection of LPS without suppressing the cytokine expression in the airpouch. Collectively, our study demonstrates that signaling of peripheral inflammation to the CNS is modulated dynamically by peripheral inflammatory kinetics. Specifically, euflammation can offer effective protection against both bacterial infection and endotoxin induced neuroinflammation.
a b s t r a c t
Peripheral inflammation can trigger a number of neuroinflammatory events in the CNS, such as activation of microglia and increases of proinflammatory cytokines. We have previously identified an interesting phenomenon, termed ''euflammation", which can be induced by repeated subthreshold infectious challenges. Euflammation causes innate immune alterations without overt neuroimmune activation. In the current study, we examined the protective effect of euflammation against peripheral inflammationinduced neuroinflammation and the underlying mechanisms. When Escherichia coli or lipopolysaccharide (LPS) was injected inside or outside the euflammation induction locus (EIL), sickness behavior, global microglial activation, proinflammatory cytokine production in the brain, expression of endothelial cyclooxygenase II and induction of c-fos expression in the paraventricular nucleus of the hypothalamus were all attenuated in the euflammatory mice compared with those in the control unprimed mice. Euflammation also modulated innate immunity outside the EIL by upregulating receptors for pathogen-associated molecular patterns in spleen cells. In addition, euflammation attenuated CNS activation in response to an intra-airpouch (outside the EIL) injection of LPS without suppressing the cytokine expression in the airpouch. Collectively, our study demonstrates that signaling of peripheral inflammation to the CNS is modulated dynamically by peripheral inflammatory kinetics. Specifically, euflammation can offer effective protection against both bacterial infection and endotoxin induced neuroinflammation.
Ó 2016 Elsevier Inc. All rights reserved.
Introduction
Peripheral inflammation triggers the production and release of inflammatory cytokines, which propagate peripheral inflammatory signaling to the brain (Galic et al., 2012) , causing inflammatory cytokine expression in the brain that mediates neuronal excitability and ultimately behavioral abnormalities (Dantzer et al., 2008) . This neuroimmune activation theory has been well-supported by mounting evidence demonstrating signal transduction at the brain endothelium, activation of glial cells and increases of proinflammatory cytokines in the brain after peripheral immune challenges (Laye et al., 1994; Pyter et al., 2009; Quan et al., 1999; Reyes et al., 1999; Riazi et al., 2008) . Such neuroinflammatory manifestation, however, is not the only consequence of peripheral inflammation. In our previous studies, we found subthreshold levels of localized infection may not cause the central consequences of peripheral inflammation. Further, a prior subthreshold infectious challenge can prime the host to more effectively combat a subsequent larger infectious load while maintaining neuroimmune quiescence. We have termed the inflammation induced by repeated subthreshold infectious challenges ''euflammation" (Chen et al., 2013; Tarr et al., 2014) . Although the altered innate immunity caused by euflammation has been previously characterized, it remains to be determined whether priming the host with euflammation could alleviate neuroinflammation induced by peripheral immune challenges.
In the current study, results showed that euflammation effectively attenuated microglial activation and cytokine expression in the brain in response to Escherichia coli or LPS challenges.
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